(Q64954141)

English

Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial.

scientific article published in January 1985

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

phase III clinical trial

1 reference

based on heuristic

inferred from title

head and neck squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

R P Morton

1

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

F Rugman

2

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

E B Dorman

3

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

P J Stoney

4

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

J A Wilson

5

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

M McCormick

6

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

A Veevers

7

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

P M Stell

8

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

publication date

1 January 1985

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

15

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

3

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

283-289

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

https://scigraph.springernature.com/pub.10.1007/bf00263902

0 references

Survival after "palliative" cytotoxic chemotherapy for head-and-neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical trial methodology

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of short-course multiple drug chemotherapy to benefit patients with recurrent or metastatic head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary results of a randomized E.O.R.T.C. study comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

'Average' survival times after treatment of cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential chemotherapy and radiotherapy in advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2414023

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00263902

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 July 2019

http://europepmc.org/abstract/MED/2414023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64954141&oldid=1502801262"